Medical Care
Global In Vitro Assays to Diagnose Infectious Diseases Market Research Report 2025
- May 05, 25
- ID: 228127
- Pages: 86
- Figures: 83
- Views: 39
The global market for In Vitro Assays to Diagnose Infectious Diseases was valued at US$ 3375 million in the year 2024 and is projected to reach a revised size of US$ 3066 million by 2031, growing at a CAGR of -1.4% during the forecast period.
In Vitro Assays to Diagnose Infectious Diseases market refers to the use of diagnostic tests and devices to detect and diagnose infectious diseases in biological samples such as blood, urine, and other bodily fluids. These tests are performed in vitro, meaning outside of the body in a laboratory setting. The IVD market for infectious diseases includes a range of tests such as immunoassays, molecular diagnostics, and microbiology culture tests, among others. These tests aid in the identification of infectious agents such as bacteria, viruses, fungi, and parasites, and help in the management and treatment of infectious diseases.
Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is a highly sensitive and specific assay that detects the presence of antigens or antibodies in patient samples. ELISA can be used to diagnose a wide range of infectious diseases, including HIV, hepatitis, and Lyme disease.
This report aims to provide a comprehensive presentation of the global market for In Vitro Assays to Diagnose Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Assays to Diagnose Infectious Diseases.
The In Vitro Assays to Diagnose Infectious Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Assays to Diagnose Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Assays to Diagnose Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
QIAGEN
BD
bioMerieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.、
iemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc
Segment by Type
Immunoassay
Molecular Diagnosis
Others
Segment by Application
Streptococcus
Clostridium Difficile
Candida
Tuberculosis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Assays to Diagnose Infectious Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In Vitro Assays to Diagnose Infectious Diseases market refers to the use of diagnostic tests and devices to detect and diagnose infectious diseases in biological samples such as blood, urine, and other bodily fluids. These tests are performed in vitro, meaning outside of the body in a laboratory setting. The IVD market for infectious diseases includes a range of tests such as immunoassays, molecular diagnostics, and microbiology culture tests, among others. These tests aid in the identification of infectious agents such as bacteria, viruses, fungi, and parasites, and help in the management and treatment of infectious diseases.
Enzyme-Linked Immunosorbent Assay (ELISA): ELISA is a highly sensitive and specific assay that detects the presence of antigens or antibodies in patient samples. ELISA can be used to diagnose a wide range of infectious diseases, including HIV, hepatitis, and Lyme disease.
This report aims to provide a comprehensive presentation of the global market for In Vitro Assays to Diagnose Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vitro Assays to Diagnose Infectious Diseases.
The In Vitro Assays to Diagnose Infectious Diseases market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In Vitro Assays to Diagnose Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vitro Assays to Diagnose Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
QIAGEN
BD
bioMerieux SA
F. Hoffmann-La Roche, Ltd.
Hologic, Inc. (Gen-Probe)
Abbott
Quidel Corp.、
iemens Healthineers AG
Bio-Rad Laboratories, Inc.
Danaher Corp.
OraSure Technologies, Inc
Segment by Type
Immunoassay
Molecular Diagnosis
Others
Segment by Application
Streptococcus
Clostridium Difficile
Candida
Tuberculosis
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vitro Assays to Diagnose Infectious Diseases company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoassay
1.2.3 Molecular Diagnosis
1.2.4 Others
1.3 Market by Application
1.3.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Streptococcus
1.3.3 Clostridium Difficile
1.3.4 Candida
1.3.5 Tuberculosis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Perspective (2020-2031)
2.2 Global In Vitro Assays to Diagnose Infectious Diseases Growth Trends by Region
2.2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Region (2020-2025)
2.2.3 In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Region (2026-2031)
2.3 In Vitro Assays to Diagnose Infectious Diseases Market Dynamics
2.3.1 In Vitro Assays to Diagnose Infectious Diseases Industry Trends
2.3.2 In Vitro Assays to Diagnose Infectious Diseases Market Drivers
2.3.3 In Vitro Assays to Diagnose Infectious Diseases Market Challenges
2.3.4 In Vitro Assays to Diagnose Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Revenue
3.1.1 Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Revenue (2020-2025)
3.1.2 Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Players (2020-2025)
3.2 Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vitro Assays to Diagnose Infectious Diseases Revenue
3.4 Global In Vitro Assays to Diagnose Infectious Diseases Market Concentration Ratio
3.4.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Assays to Diagnose Infectious Diseases Revenue in 2024
3.5 Global Key Players of In Vitro Assays to Diagnose Infectious Diseases Head office and Area Served
3.6 Global Key Players of In Vitro Assays to Diagnose Infectious Diseases, Product and Application
3.7 Global Key Players of In Vitro Assays to Diagnose Infectious Diseases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Assays to Diagnose Infectious Diseases Breakdown Data by Type
4.1 Global In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Type (2020-2025)
4.2 Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Type (2026-2031)
5 In Vitro Assays to Diagnose Infectious Diseases Breakdown Data by Application
5.1 Global In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Application (2020-2025)
5.2 Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vitro Assays to Diagnose Infectious Diseases Market Size (2020-2031)
6.2 North America In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025)
6.4 North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size (2020-2031)
7.2 Europe In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025)
7.4 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size (2020-2031)
8.2 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size (2020-2031)
9.2 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025)
9.4 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size (2020-2031)
10.2 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Details
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Introduction
11.1.4 QIAGEN Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.1.5 QIAGEN Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD In Vitro Assays to Diagnose Infectious Diseases Introduction
11.2.4 BD Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.2.5 BD Recent Development
11.3 bioMerieux SA
11.3.1 bioMerieux SA Company Details
11.3.2 bioMerieux SA Business Overview
11.3.3 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Introduction
11.3.4 bioMerieux SA Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.3.5 bioMerieux SA Recent Development
11.4 F. Hoffmann-La Roche, Ltd.
11.4.1 F. Hoffmann-La Roche, Ltd. Company Details
11.4.2 F. Hoffmann-La Roche, Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.4.4 F. Hoffmann-La Roche, Ltd. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.4.5 F. Hoffmann-La Roche, Ltd. Recent Development
11.5 Hologic, Inc. (Gen-Probe)
11.5.1 Hologic, Inc. (Gen-Probe) Company Details
11.5.2 Hologic, Inc. (Gen-Probe) Business Overview
11.5.3 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Introduction
11.5.4 Hologic, Inc. (Gen-Probe) Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.5.5 Hologic, Inc. (Gen-Probe) Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott In Vitro Assays to Diagnose Infectious Diseases Introduction
11.6.4 Abbott Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.6.5 Abbott Recent Development
11.7 Quidel Corp.、
11.7.1 Quidel Corp.、 Company Details
11.7.2 Quidel Corp.、 Business Overview
11.7.3 Quidel Corp.、 In Vitro Assays to Diagnose Infectious Diseases Introduction
11.7.4 Quidel Corp.、 Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.7.5 Quidel Corp.、 Recent Development
11.8 iemens Healthineers AG
11.8.1 iemens Healthineers AG Company Details
11.8.2 iemens Healthineers AG Business Overview
11.8.3 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Introduction
11.8.4 iemens Healthineers AG Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.8.5 iemens Healthineers AG Recent Development
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Details
11.9.2 Bio-Rad Laboratories, Inc. Business Overview
11.9.3 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.9.4 Bio-Rad Laboratories, Inc. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.9.5 Bio-Rad Laboratories, Inc. Recent Development
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Details
11.10.2 Danaher Corp. Business Overview
11.10.3 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.10.4 Danaher Corp. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.10.5 Danaher Corp. Recent Development
11.11 OraSure Technologies, Inc
11.11.1 OraSure Technologies, Inc Company Details
11.11.2 OraSure Technologies, Inc Business Overview
11.11.3 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Introduction
11.11.4 OraSure Technologies, Inc Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.11.5 OraSure Technologies, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoassay
1.2.3 Molecular Diagnosis
1.2.4 Others
1.3 Market by Application
1.3.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Streptococcus
1.3.3 Clostridium Difficile
1.3.4 Candida
1.3.5 Tuberculosis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Perspective (2020-2031)
2.2 Global In Vitro Assays to Diagnose Infectious Diseases Growth Trends by Region
2.2.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Region (2020-2025)
2.2.3 In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Region (2026-2031)
2.3 In Vitro Assays to Diagnose Infectious Diseases Market Dynamics
2.3.1 In Vitro Assays to Diagnose Infectious Diseases Industry Trends
2.3.2 In Vitro Assays to Diagnose Infectious Diseases Market Drivers
2.3.3 In Vitro Assays to Diagnose Infectious Diseases Market Challenges
2.3.4 In Vitro Assays to Diagnose Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Revenue
3.1.1 Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Revenue (2020-2025)
3.1.2 Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Players (2020-2025)
3.2 Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In Vitro Assays to Diagnose Infectious Diseases Revenue
3.4 Global In Vitro Assays to Diagnose Infectious Diseases Market Concentration Ratio
3.4.1 Global In Vitro Assays to Diagnose Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Assays to Diagnose Infectious Diseases Revenue in 2024
3.5 Global Key Players of In Vitro Assays to Diagnose Infectious Diseases Head office and Area Served
3.6 Global Key Players of In Vitro Assays to Diagnose Infectious Diseases, Product and Application
3.7 Global Key Players of In Vitro Assays to Diagnose Infectious Diseases, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Assays to Diagnose Infectious Diseases Breakdown Data by Type
4.1 Global In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Type (2020-2025)
4.2 Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Type (2026-2031)
5 In Vitro Assays to Diagnose Infectious Diseases Breakdown Data by Application
5.1 Global In Vitro Assays to Diagnose Infectious Diseases Historic Market Size by Application (2020-2025)
5.2 Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In Vitro Assays to Diagnose Infectious Diseases Market Size (2020-2031)
6.2 North America In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025)
6.4 North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size (2020-2031)
7.2 Europe In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025)
7.4 Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size (2020-2031)
8.2 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2020-2025)
8.4 Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size (2020-2031)
9.2 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025)
9.4 Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size (2020-2031)
10.2 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025)
10.4 Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Details
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN In Vitro Assays to Diagnose Infectious Diseases Introduction
11.1.4 QIAGEN Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.1.5 QIAGEN Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD In Vitro Assays to Diagnose Infectious Diseases Introduction
11.2.4 BD Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.2.5 BD Recent Development
11.3 bioMerieux SA
11.3.1 bioMerieux SA Company Details
11.3.2 bioMerieux SA Business Overview
11.3.3 bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Introduction
11.3.4 bioMerieux SA Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.3.5 bioMerieux SA Recent Development
11.4 F. Hoffmann-La Roche, Ltd.
11.4.1 F. Hoffmann-La Roche, Ltd. Company Details
11.4.2 F. Hoffmann-La Roche, Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.4.4 F. Hoffmann-La Roche, Ltd. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.4.5 F. Hoffmann-La Roche, Ltd. Recent Development
11.5 Hologic, Inc. (Gen-Probe)
11.5.1 Hologic, Inc. (Gen-Probe) Company Details
11.5.2 Hologic, Inc. (Gen-Probe) Business Overview
11.5.3 Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Introduction
11.5.4 Hologic, Inc. (Gen-Probe) Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.5.5 Hologic, Inc. (Gen-Probe) Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott In Vitro Assays to Diagnose Infectious Diseases Introduction
11.6.4 Abbott Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.6.5 Abbott Recent Development
11.7 Quidel Corp.、
11.7.1 Quidel Corp.、 Company Details
11.7.2 Quidel Corp.、 Business Overview
11.7.3 Quidel Corp.、 In Vitro Assays to Diagnose Infectious Diseases Introduction
11.7.4 Quidel Corp.、 Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.7.5 Quidel Corp.、 Recent Development
11.8 iemens Healthineers AG
11.8.1 iemens Healthineers AG Company Details
11.8.2 iemens Healthineers AG Business Overview
11.8.3 iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Introduction
11.8.4 iemens Healthineers AG Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.8.5 iemens Healthineers AG Recent Development
11.9 Bio-Rad Laboratories, Inc.
11.9.1 Bio-Rad Laboratories, Inc. Company Details
11.9.2 Bio-Rad Laboratories, Inc. Business Overview
11.9.3 Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.9.4 Bio-Rad Laboratories, Inc. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.9.5 Bio-Rad Laboratories, Inc. Recent Development
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Details
11.10.2 Danaher Corp. Business Overview
11.10.3 Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Introduction
11.10.4 Danaher Corp. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.10.5 Danaher Corp. Recent Development
11.11 OraSure Technologies, Inc
11.11.1 OraSure Technologies, Inc Company Details
11.11.2 OraSure Technologies, Inc Business Overview
11.11.3 OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Introduction
11.11.4 OraSure Technologies, Inc Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
11.11.5 OraSure Technologies, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunoassay
Table 3. Key Players of Molecular Diagnosis
Table 4. Key Players of Others
Table 5. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2020-2025)
Table 9. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2026-2031)
Table 11. In Vitro Assays to Diagnose Infectious Diseases Market Trends
Table 12. In Vitro Assays to Diagnose Infectious Diseases Market Drivers
Table 13. In Vitro Assays to Diagnose Infectious Diseases Market Challenges
Table 14. In Vitro Assays to Diagnose Infectious Diseases Market Restraints
Table 15. Global In Vitro Assays to Diagnose Infectious Diseases Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Players (2020-2025)
Table 17. Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Assays to Diagnose Infectious Diseases as of 2024)
Table 18. Ranking of Global Top In Vitro Assays to Diagnose Infectious Diseases Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by In Vitro Assays to Diagnose Infectious Diseases Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of In Vitro Assays to Diagnose Infectious Diseases, Headquarters and Area Served
Table 21. Global Key Players of In Vitro Assays to Diagnose Infectious Diseases, Product and Application
Table 22. Global Key Players of In Vitro Assays to Diagnose Infectious Diseases, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Type (2020-2025)
Table 26. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Type (2026-2031)
Table 28. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Application (2020-2025)
Table 30. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Application (2026-2031)
Table 32. North America In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 47. QIAGEN Company Details
Table 48. QIAGEN Business Overview
Table 49. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product
Table 50. QIAGEN Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 51. QIAGEN Recent Development
Table 52. BD Company Details
Table 53. BD Business Overview
Table 54. BD In Vitro Assays to Diagnose Infectious Diseases Product
Table 55. BD Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 56. BD Recent Development
Table 57. bioMerieux SA Company Details
Table 58. bioMerieux SA Business Overview
Table 59. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product
Table 60. bioMerieux SA Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 61. bioMerieux SA Recent Development
Table 62. F. Hoffmann-La Roche, Ltd. Company Details
Table 63. F. Hoffmann-La Roche, Ltd. Business Overview
Table 64. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product
Table 65. F. Hoffmann-La Roche, Ltd. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 66. F. Hoffmann-La Roche, Ltd. Recent Development
Table 67. Hologic, Inc. (Gen-Probe) Company Details
Table 68. Hologic, Inc. (Gen-Probe) Business Overview
Table 69. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product
Table 70. Hologic, Inc. (Gen-Probe) Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 71. Hologic, Inc. (Gen-Probe) Recent Development
Table 72. Abbott Company Details
Table 73. Abbott Business Overview
Table 74. Abbott In Vitro Assays to Diagnose Infectious Diseases Product
Table 75. Abbott Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 76. Abbott Recent Development
Table 77. Quidel Corp.、 Company Details
Table 78. Quidel Corp.、 Business Overview
Table 79. Quidel Corp.、 In Vitro Assays to Diagnose Infectious Diseases Product
Table 80. Quidel Corp.、 Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 81. Quidel Corp.、 Recent Development
Table 82. iemens Healthineers AG Company Details
Table 83. iemens Healthineers AG Business Overview
Table 84. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product
Table 85. iemens Healthineers AG Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 86. iemens Healthineers AG Recent Development
Table 87. Bio-Rad Laboratories, Inc. Company Details
Table 88. Bio-Rad Laboratories, Inc. Business Overview
Table 89. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product
Table 90. Bio-Rad Laboratories, Inc. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 91. Bio-Rad Laboratories, Inc. Recent Development
Table 92. Danaher Corp. Company Details
Table 93. Danaher Corp. Business Overview
Table 94. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product
Table 95. Danaher Corp. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 96. Danaher Corp. Recent Development
Table 97. OraSure Technologies, Inc Company Details
Table 98. OraSure Technologies, Inc Business Overview
Table 99. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product
Table 100. OraSure Technologies, Inc Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 101. OraSure Technologies, Inc Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. In Vitro Assays to Diagnose Infectious Diseases Picture
Figure 2. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Type: 2024 VS 2031
Figure 4. Immunoassay Features
Figure 5. Molecular Diagnosis Features
Figure 6. Others Features
Figure 7. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Application: 2024 VS 2031
Figure 9. Streptococcus Case Studies
Figure 10. Clostridium Difficile Case Studies
Figure 11. Candida Case Studies
Figure 12. Tuberculosis Case Studies
Figure 13. Others Case Studies
Figure 14. In Vitro Assays to Diagnose Infectious Diseases Report Years Considered
Figure 15. Global In Vitro Assays to Diagnose Infectious Diseases Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global In Vitro Assays to Diagnose Infectious Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region: 2024 VS 2031
Figure 18. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Players in 2024
Figure 19. Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Assays to Diagnose Infectious Diseases as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by In Vitro Assays to Diagnose Infectious Diseases Revenue in 2024
Figure 21. North America In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2020-2031)
Figure 23. United States In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2020-2031)
Figure 27. Germany In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2020-2031)
Figure 35. China In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2020-2031)
Figure 43. Mexico In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2020-2031)
Figure 47. Turkey In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. QIAGEN Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 51. BD Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 52. bioMerieux SA Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 53. F. Hoffmann-La Roche, Ltd. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 54. Hologic, Inc. (Gen-Probe) Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 55. Abbott Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 56. Quidel Corp.、 Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 57. iemens Healthineers AG Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 58. Bio-Rad Laboratories, Inc. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 59. Danaher Corp. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 60. OraSure Technologies, Inc Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immunoassay
Table 3. Key Players of Molecular Diagnosis
Table 4. Key Players of Others
Table 5. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2020-2025)
Table 9. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2026-2031)
Table 11. In Vitro Assays to Diagnose Infectious Diseases Market Trends
Table 12. In Vitro Assays to Diagnose Infectious Diseases Market Drivers
Table 13. In Vitro Assays to Diagnose Infectious Diseases Market Challenges
Table 14. In Vitro Assays to Diagnose Infectious Diseases Market Restraints
Table 15. Global In Vitro Assays to Diagnose Infectious Diseases Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Players (2020-2025)
Table 17. Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Assays to Diagnose Infectious Diseases as of 2024)
Table 18. Ranking of Global Top In Vitro Assays to Diagnose Infectious Diseases Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by In Vitro Assays to Diagnose Infectious Diseases Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of In Vitro Assays to Diagnose Infectious Diseases, Headquarters and Area Served
Table 21. Global Key Players of In Vitro Assays to Diagnose Infectious Diseases, Product and Application
Table 22. Global Key Players of In Vitro Assays to Diagnose Infectious Diseases, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Type (2020-2025)
Table 26. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Type (2026-2031)
Table 28. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Application (2020-2025)
Table 30. Global In Vitro Assays to Diagnose Infectious Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global In Vitro Assays to Diagnose Infectious Diseases Revenue Market Share by Application (2026-2031)
Table 32. North America In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 47. QIAGEN Company Details
Table 48. QIAGEN Business Overview
Table 49. QIAGEN In Vitro Assays to Diagnose Infectious Diseases Product
Table 50. QIAGEN Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 51. QIAGEN Recent Development
Table 52. BD Company Details
Table 53. BD Business Overview
Table 54. BD In Vitro Assays to Diagnose Infectious Diseases Product
Table 55. BD Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 56. BD Recent Development
Table 57. bioMerieux SA Company Details
Table 58. bioMerieux SA Business Overview
Table 59. bioMerieux SA In Vitro Assays to Diagnose Infectious Diseases Product
Table 60. bioMerieux SA Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 61. bioMerieux SA Recent Development
Table 62. F. Hoffmann-La Roche, Ltd. Company Details
Table 63. F. Hoffmann-La Roche, Ltd. Business Overview
Table 64. F. Hoffmann-La Roche, Ltd. In Vitro Assays to Diagnose Infectious Diseases Product
Table 65. F. Hoffmann-La Roche, Ltd. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 66. F. Hoffmann-La Roche, Ltd. Recent Development
Table 67. Hologic, Inc. (Gen-Probe) Company Details
Table 68. Hologic, Inc. (Gen-Probe) Business Overview
Table 69. Hologic, Inc. (Gen-Probe) In Vitro Assays to Diagnose Infectious Diseases Product
Table 70. Hologic, Inc. (Gen-Probe) Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 71. Hologic, Inc. (Gen-Probe) Recent Development
Table 72. Abbott Company Details
Table 73. Abbott Business Overview
Table 74. Abbott In Vitro Assays to Diagnose Infectious Diseases Product
Table 75. Abbott Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 76. Abbott Recent Development
Table 77. Quidel Corp.、 Company Details
Table 78. Quidel Corp.、 Business Overview
Table 79. Quidel Corp.、 In Vitro Assays to Diagnose Infectious Diseases Product
Table 80. Quidel Corp.、 Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 81. Quidel Corp.、 Recent Development
Table 82. iemens Healthineers AG Company Details
Table 83. iemens Healthineers AG Business Overview
Table 84. iemens Healthineers AG In Vitro Assays to Diagnose Infectious Diseases Product
Table 85. iemens Healthineers AG Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 86. iemens Healthineers AG Recent Development
Table 87. Bio-Rad Laboratories, Inc. Company Details
Table 88. Bio-Rad Laboratories, Inc. Business Overview
Table 89. Bio-Rad Laboratories, Inc. In Vitro Assays to Diagnose Infectious Diseases Product
Table 90. Bio-Rad Laboratories, Inc. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 91. Bio-Rad Laboratories, Inc. Recent Development
Table 92. Danaher Corp. Company Details
Table 93. Danaher Corp. Business Overview
Table 94. Danaher Corp. In Vitro Assays to Diagnose Infectious Diseases Product
Table 95. Danaher Corp. Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 96. Danaher Corp. Recent Development
Table 97. OraSure Technologies, Inc Company Details
Table 98. OraSure Technologies, Inc Business Overview
Table 99. OraSure Technologies, Inc In Vitro Assays to Diagnose Infectious Diseases Product
Table 100. OraSure Technologies, Inc Revenue in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025) & (US$ Million)
Table 101. OraSure Technologies, Inc Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. In Vitro Assays to Diagnose Infectious Diseases Picture
Figure 2. Global In Vitro Assays to Diagnose Infectious Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Type: 2024 VS 2031
Figure 4. Immunoassay Features
Figure 5. Molecular Diagnosis Features
Figure 6. Others Features
Figure 7. Global In Vitro Assays to Diagnose Infectious Diseases Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Application: 2024 VS 2031
Figure 9. Streptococcus Case Studies
Figure 10. Clostridium Difficile Case Studies
Figure 11. Candida Case Studies
Figure 12. Tuberculosis Case Studies
Figure 13. Others Case Studies
Figure 14. In Vitro Assays to Diagnose Infectious Diseases Report Years Considered
Figure 15. Global In Vitro Assays to Diagnose Infectious Diseases Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global In Vitro Assays to Diagnose Infectious Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Region: 2024 VS 2031
Figure 18. Global In Vitro Assays to Diagnose Infectious Diseases Market Share by Players in 2024
Figure 19. Global Top In Vitro Assays to Diagnose Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vitro Assays to Diagnose Infectious Diseases as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by In Vitro Assays to Diagnose Infectious Diseases Revenue in 2024
Figure 21. North America In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2020-2031)
Figure 23. United States In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2020-2031)
Figure 27. Germany In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific In Vitro Assays to Diagnose Infectious Diseases Market Share by Region (2020-2031)
Figure 35. China In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2020-2031)
Figure 43. Mexico In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa In Vitro Assays to Diagnose Infectious Diseases Market Share by Country (2020-2031)
Figure 47. Turkey In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE In Vitro Assays to Diagnose Infectious Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. QIAGEN Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 51. BD Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 52. bioMerieux SA Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 53. F. Hoffmann-La Roche, Ltd. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 54. Hologic, Inc. (Gen-Probe) Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 55. Abbott Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 56. Quidel Corp.、 Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 57. iemens Healthineers AG Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 58. Bio-Rad Laboratories, Inc. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 59. Danaher Corp. Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 60. OraSure Technologies, Inc Revenue Growth Rate in In Vitro Assays to Diagnose Infectious Diseases Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232